Federal prosecutors want four former Synthes Inc. executives to spend up to a year in jail after they pleaded guilty to their roles in an un-authorized bone cement trial in which three patients died during surgery.
Johnson and Johnson
Appeals court backs BSX over Cordis | Legal Roundup
Appeals court backs Boston Scientific in patent spat with J&J’s Cordis Corp.
Indiana Gov. Mitch Daniels signs on for medical device conference
Indiana Gov. Mitchell Daniels won’t be running for the GOP nomination in 2012, but his name still draws water for medical device makers, who picked him to address the annual conference of the country’s largest medical device industry council.
The Advanced Medical Technology Assn. said today that the governor of the Hoosier State will be a featured speaker at AdvaMed 2011, the council’s annual fall gathering.
Johnson & Johnson fights back against fake diabetes test strips
Johnson & Johnson’s (NYSE:JNJ) LifeScan unit reached a settlement banning a South African distributor from buying or selling the company’s OneTouch diabetes test strips, regardless of whether the strips are real or counterfeit.
JNJ claimed the African distributor, Aristides Spanellis, ran a “sophisticated international operation” in which diabetes test strips were purchased in Turkey, Saudi Arabia and Pakistan and repackaged in OneTouch boxes for export to the U.S., Dow Jones news service reported.
DePuy Pinnacle hip implant lawsuits consolidated in Texas | Legal Roundup
A group of at least 57 product liability lawsuits filed against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics over one of its metal-on-metal hip implants were consolidated in the U.S. District Court for Northern Texas.
Tryton poaches new CEO from AngioDynamics | Personnel Moves
Shawn McCarthy traded his vice president role at AngioDynamics Inc. (NSDQ:ANGO) for the corner office at Tryton Medical Inc., assuming the president and CEO spot at the Durham, N.C.-based stent maker.
McCarthy was senior vice president and general manager of AngioDynamics’ vascular and oncology surgery business units. AngioDynamics reported $12.3 million in net income on $216 million in sales last year. Tryton is a much smaller operation, posting $1.7 million to the top line in 2010.
Pain wars: Industry giants battle to lead the house of pain
Stents: Medtronic’s subclavian approach for valve-replacement device achieved “excellent” results in clinical trial | PCR 2011 Roundup
AHA: Obama drastically underestimated costs of ACOs
MASSDEVICE ON CALL | Accountable Care Organizations, President Obama’s central idea for getting quality medical care at less cost, met more resistance as hospitals say actual costs could be 10 times more than projected.
Recent Medicare projections put costs at around $1.8 million in the first year, but the American Hospital Association says the programs are more likely to cost between $11 and $26 million. The AHA estimates came from studies that ran prior to the release of ACO regulations.
$1 billion: The price for settling federal beef over J&J’s drug marketing
MASSDEVICE ON CALL — $1 billion: The price for settling federal beef over J&J’s drug marketing. Federal prosecutors are seeking about $1 billion from Johnson & Johnson (NYSE:JNJ) to settle a criminal investigation into the company’s marketing of an antipsychotic drug, according to The Wall Street Journal.